Chengjuan Chen

873 total citations
30 papers, 659 citations indexed

About

Chengjuan Chen is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Chengjuan Chen has authored 30 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Chengjuan Chen's work include Cytokine Signaling Pathways and Interactions (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Natural Compounds in Disease Treatment (4 papers). Chengjuan Chen is often cited by papers focused on Cytokine Signaling Pathways and Interactions (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Natural Compounds in Disease Treatment (4 papers). Chengjuan Chen collaborates with scholars based in China, United States and Macao. Chengjuan Chen's co-authors include Tiantai Zhang, Gaona Shi, Shuai Shao, Yu Zhou, Dongmei Wang, Min Hu, Lei Wu, Jian‐Gong Shi, Lei Wu and Lei Shu and has published in prestigious journals such as Science Advances, Molecules and Pharmacology & Therapeutics.

In The Last Decade

Chengjuan Chen

29 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengjuan Chen China 17 281 132 118 94 90 30 659
Lei Bi China 17 543 1.9× 218 1.7× 95 0.8× 44 0.5× 24 0.3× 46 977
Ellen Herlaar United Kingdom 6 324 1.2× 104 0.8× 228 1.9× 45 0.5× 28 0.3× 8 699
Ki Beom Bae South Korea 20 526 1.9× 309 2.3× 112 0.9× 38 0.4× 20 0.2× 69 1.2k
Begoña Cánovas Spain 6 432 1.5× 125 0.9× 76 0.6× 19 0.2× 68 0.8× 8 677
Amal Kamal Abdel‐Aziz Egypt 18 438 1.6× 207 1.6× 68 0.6× 108 1.1× 37 0.4× 34 1.1k
Kui Sheng Chen China 2 606 2.2× 216 1.6× 97 0.8× 35 0.4× 23 0.3× 5 1.0k
Mihail Buse Romania 8 511 1.8× 180 1.4× 71 0.6× 25 0.3× 37 0.4× 14 878
Haojian Zhang China 16 662 2.4× 168 1.3× 119 1.0× 226 2.4× 19 0.2× 49 1.2k
Constantin Busuioc Romania 5 430 1.5× 179 1.4× 62 0.5× 26 0.3× 35 0.4× 13 722

Countries citing papers authored by Chengjuan Chen

Since Specialization
Citations

This map shows the geographic impact of Chengjuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengjuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengjuan Chen more than expected).

Fields of papers citing papers by Chengjuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengjuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengjuan Chen. The network helps show where Chengjuan Chen may publish in the future.

Co-authorship network of co-authors of Chengjuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chengjuan Chen. A scholar is included among the top collaborators of Chengjuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengjuan Chen. Chengjuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feng, Yifan, Chengjuan Chen, Qingyang Zhang, et al.. (2025). Recent advances in interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors and PROTACs. Chinese Chemical Letters. 36(12). 110963–110963.
2.
Feng, Yifan, et al.. (2024). Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharmaceutica Sinica B. 14(12). 5091–5105. 12 indexed citations
3.
Shao, Shuai, Chengjuan Chen, Gaona Shi, et al.. (2023). JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes. Acta Pharmaceutica Sinica B. 13(10). 4185–4201. 14 indexed citations
4.
Shi, Gaona, Yu Zhou, Chengjuan Chen, et al.. (2023). Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells. Acta Pharmaceutica Sinica B. 13(6). 2778–2794. 24 indexed citations
5.
Chen, Chengjuan, Chengbo Xu, Shuai Shao, et al.. (2023). A synthetic derivative of bioactive constituents from Isatis indigotica ameliorates hypersensitivity and arthritis by inhibiting JAK2-STAT3 pathway in mice. International Immunopharmacology. 124(Pt A). 110884–110884. 6 indexed citations
6.
Zhou, Yu, Tianming Yang, Gaona Shi, et al.. (2022). Celastrol Targets Cullin-Associated and Neddylation-Dissociated 1 to Prevent Fibroblast–Myofibroblast Transformation against Pulmonary Fibrosis. ACS Chemical Biology. 17(10). 2734–2743. 17 indexed citations
7.
Chen, Chengjuan, Gaona Shi, Yu Zhou, et al.. (2022). A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal. Science Advances. 8(33). eabo4363–eabo4363. 31 indexed citations
8.
Zang, Yingda, Yu Zhou, Chengjuan Chen, et al.. (2021). Exploring a novel triptolide derivative possess anti-colitis effect via regulating T cell differentiation. International Immunopharmacology. 94. 107472–107472. 15 indexed citations
9.
Shao, Shuai, Chengbo Xu, Chengjuan Chen, et al.. (2021). Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice. Journal of Neuroinflammation. 18(1). 142–142. 64 indexed citations
10.
Chen, Chengjuan, et al.. (2021). Emerging small-molecule inhibitors of the Bruton’s tyrosine kinase (BTK): Current development. European Journal of Medicinal Chemistry. 217. 113329–113329. 53 indexed citations
11.
Shao, Shuai, Chengjuan Chen, Gaona Shi, et al.. (2021). Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacology & Therapeutics. 227. 107880–107880. 46 indexed citations
12.
Zang, Yingda, Fangfang Lai, Chuang‐Jun Li, et al.. (2020). Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies. European Journal of Medicinal Chemistry. 190. 112079–112079. 25 indexed citations
13.
Shao, Shuai, Huan Xia, Min Hu, et al.. (2020). Isotalatizidine, a C19-diterpenoid alkaloid, attenuates chronic neuropathic pain through stimulating ERK/CREB signaling pathway-mediated microglial dynorphin A expression. Journal of Neuroinflammation. 17(1). 13–13. 34 indexed citations
14.
15.
Shu, Lei, Chengjuan Chen, Manman Wang, et al.. (2020). Design, synthesis, and pharmacological evaluation of 4- or 6-phenyl-pyrimidine derivatives as novel and selective Janus kinase 3 inhibitors. European Journal of Medicinal Chemistry. 191. 112148–112148. 30 indexed citations
16.
Zang, Yingda, Yu Zhou, Chengjuan Chen, et al.. (2020). A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype. Biomedicine & Pharmacotherapy. 126. 110084–110084. 16 indexed citations
17.
Wang, Dongmei, Min Hu, Xinpeng Li, et al.. (2019). Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 168. 207–220. 30 indexed citations
18.
Hu, Min, Chengbo Xu, Chao Yang, et al.. (2019). Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2V617F against myeloproliferative neoplasms. Journal of Experimental & Clinical Cancer Research. 38(1). 49–49. 19 indexed citations
19.
Li, Jinze, Xiaowei Ma, Yu Wang, et al.. (2018). Methyl Salicylate Lactoside Protects Neurons Ameliorating Cognitive Disorder Through Inhibiting Amyloid Beta-Induced Neuroinflammatory Response in Alzheimer’s Disease. Frontiers in Aging Neuroscience. 10. 85–85. 12 indexed citations
20.
Chen, Chengjuan, et al.. (2018). Structure-based design and synthesis of 1H-pyrazolo[3,4-d]pyrimidin-4-amino derivatives as Janus kinase 3 inhibitors. Bioorganic & Medicinal Chemistry. 26(17). 4774–4786. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Bi Breakdown of academic impact, for papers by Ellen Herlaar Breakdown of academic impact, for papers by Ki Beom Bae Breakdown of academic impact, for papers by Begoña Cánovas Breakdown of academic impact, for papers by Amal Kamal Abdel‐Aziz Breakdown of academic impact, for papers by Kui Sheng Chen Breakdown of academic impact, for papers by Mihail Buse Breakdown of academic impact, for papers by Haojian Zhang Breakdown of academic impact, for papers by Constantin Busuioc
Rankless by CCL
2026